Related Experiment Videos
Toll-like receptors and activation of autoreactive B cells
Elizabeth A Leadbetter1, Ian R Rifkin, Ann Marshak-Rothstein
1Department of Microbiology, Boston University School of Medicine, Boston, Mass., USA.
Current Directions in Autoimmunity
|November 1, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Endothelial cell expression of STINGV154M: Gain-of-function mutation delays the resolution of UVB-induced skin injury.
The Journal of investigative dermatology·2026
The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.
bioRxiv : the preprint server for biology·2025
Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus.
Science translational medicine·2025
The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Current directions in autoimmunity·2010
TNF in host resistance to tuberculosis infection.
Current directions in autoimmunity·2010
TNF-alpha and obesity.
Current directions in autoimmunity·2010
TNF and bone.
Current directions in autoimmunity·2010
TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
Current directions in autoimmunity·2010
T cells as sources and targets of TNF: implications for immunity and autoimmunity.
Current directions in autoimmunity·2010
Envenomation-Induced Hemophagocytic Lymphohistiocytosis (HLH): First Reported Adult Case Following A Spider Bite.
European journal of case reports in internal medicine·2026